177 related articles for article (PubMed ID: 15790616)
1. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.
Wei L; Ebrahim S; Bartlett C; Davey PD; Sullivan FM; MacDonald TM
BMJ; 2005 Apr; 330(7495):821. PubMed ID: 15790616
[TBL] [Abstract][Full Text] [Related]
2. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
[TBL] [Abstract][Full Text] [Related]
3. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.
Wei L; Wang J; Thompson P; Wong S; Struthers AD; MacDonald TM
Heart; 2002 Sep; 88(3):229-33. PubMed ID: 12181210
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of statins in chronic kidney disease.
Sheng X; Murphy MJ; Macdonald TM; Wei L
QJM; 2012 Jul; 105(7):641-8. PubMed ID: 22383690
[TBL] [Abstract][Full Text] [Related]
5. Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.
Ble A; Hughes PM; Delgado J; Masoli JA; Bowman K; Zirk-Sadowski J; Mujica Mota RE; Henley WE; Melzer D
J Gerontol A Biol Sci Med Sci; 2017 Feb; 72(2):243-250. PubMed ID: 27146371
[TBL] [Abstract][Full Text] [Related]
6. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
10. Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.
Lefeber GJ; Koek HL; Souverein PC; Bouvy ML; de Boer A; Knol W
J Am Geriatr Soc; 2020 Feb; 68(2):329-336. PubMed ID: 31647578
[TBL] [Abstract][Full Text] [Related]
11. Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study.
Sheng X; Murphy MJ; MacDonald TM; Wei L
Eur J Clin Pharmacol; 2012 Aug; 68(8):1201-8. PubMed ID: 22354153
[TBL] [Abstract][Full Text] [Related]
12. Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study.
Sheng X; Wei L; Murphy MJ; MacDonald TM
Eur J Clin Pharmacol; 2009 Nov; 65(11):1071-80. PubMed ID: 19730842
[TBL] [Abstract][Full Text] [Related]
13. The effect of statins on average survival in randomised trials, an analysis of end point postponement.
Kristensen ML; Christensen PM; Hallas J
BMJ Open; 2015 Sep; 5(9):e007118. PubMed ID: 26408281
[TBL] [Abstract][Full Text] [Related]
14. Early statin initiation and outcomes in patients with acute coronary syndromes.
Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
[TBL] [Abstract][Full Text] [Related]
15. The causes and effects of socio-demographic exclusions from clinical trials.
Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P
Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564
[TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
[TBL] [Abstract][Full Text] [Related]
17. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
19. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
Khan SU; Yedlapati SH; Lone AN; Hao Q; Guyatt G; Delvaux N; Bekkering GET; Vandvik PO; Riaz IB; Li S; Aertgeerts B; Rodondi N
BMJ; 2022 May; 377():e069116. PubMed ID: 35508321
[TBL] [Abstract][Full Text] [Related]
20. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
